Oragenics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on May 9, 2009. The report discloses a material corporate governance event involving the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements.
Material Changes
Effective May 9, 2009, Dr. Marc K. Siegel resigned as a member of the Board of Directors. The filing explicitly states that Dr. Siegel resigned because he was not in agreement with the direction the company was taking and did not have confidence in the management.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, future outlook, or specific risk factors beyond the implication of internal disagreement regarding company strategy. No unusual items or contingencies were disclosed in this specific report.
Key Facts for Investor Verification
- Dr. Marc K. Siegel resigned from the Board of Directors effective May 9, 2009.
- The resignation was driven by a lack of confidence in management and disagreement with the company's strategic direction.
- The report was signed by David Hirsch, Chief Financial Officer, on May 12, 2009.
- No financial performance data is included in this specific filing.